Show simple item record

dc.contributor.authorHowell, Anthony
dc.date.accessioned2009-09-15T15:02:05Z
dc.date.available2009-09-15T15:02:05Z
dc.date.issued2002-11
dc.identifier.citationSelective oestrogen receptor downregulator. 2002, 38 Suppl 6:S61-2 Eur. J. Canceren
dc.identifier.issn0959-8049
dc.identifier.pmid12409078
dc.identifier.urihttp://hdl.handle.net/10541/81139
dc.language.isoenen
dc.subjectBreast Canceren
dc.subjectSelective Oestrogen Receptorsen
dc.subjectSelective Oestrogen Receptor Modulatorsen
dc.subject.meshBreast Neoplasms
dc.subject.meshClinical Trials as Topic
dc.subject.meshDisease Progression
dc.subject.meshDown-Regulation
dc.subject.meshEstradiol
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshNitriles
dc.subject.meshReceptors, Estrogen
dc.subject.meshRisk Factors
dc.subject.meshSelective Estrogen Receptor Modulators
dc.subject.meshTamoxifen
dc.subject.meshTriazoles
dc.titleSelective oestrogen receptor downregulator.en
dc.typeArticleen
dc.contributor.departmentCRC Department of Medical Oncology, University of Manchester, Christie Hospital NHS Trust, Manchester, UK. maria.parker@christie-tr.nwest.nhs.uken
dc.identifier.journalEuropean Journal of Canceren


This item appears in the following Collection(s)

Show simple item record